Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine Prophylaxis for P. Vivax Malaria in Pregnancy
NCT00290420Phase 4Withdrawn
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Mar 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of chloroquine in malaria, sponsored by Institut de Recherche pour le Développement. Primary endpoint: Incidence of women presenting a malaria attack during pregnancy at 2 years. Planned start Mar 2006; status: withdrawn.
02
Drugs
chloroquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00290420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290420.